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Abstract Cardiovascular diseases and diabetes mellitus
type II (DM II) are both major health problems. A large
risk factor for these diseases is the presence of the meta-
bolic syndrome. It is known that the risk of DM II can be
decreased by coffee consumption. Therefore, we examined
the association between coffee consumption and the com-
ponents of the metabolic syndrome. Prospective data from
the Amsterdam Growth and Health Longitudinal Study
(AGAHLS) is used to analyse the associations between
coffee consumption (averaged over a period from 27 till
42 years) and the components of the metabolic syndrome
(at the age of 42 years). This was done by linear regression
analyses and associations were adjusted for physical
activity, energy intake, alcohol consumption and smoking
behaviour. The results showed that moderate and high ([2
cups/day) coffee consumption was significantly associated
with lower HDL in women. For men, coffee consumption
was not associated with any of the components of the
metabolic syndrome.
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Background
Cardiovascular diseases (CVD) and diabetes mellitus type
II (DM II) are both major health problems and considerate
research has been carried out to assess the determinants of
these diseases [1–5]. A very important risk factor for these
diseases is the ‘metabolic syndrome’ [6, 7]. This consists of
five components; (1) elevated blood pressure, (2) low HDL
cholesterol levels, (3) high triglyceride levels, (4) high
fasting glucose levels and (5) abdominal obesity. When
three or more of five of the components are present, met-
abolic syndrome is diagnosed [8, 9].
The presence of the metabolic syndrome is associated
with an approximately two-fold elevation in the risk of
fatal CVD in men and nonfatal CVD in women [6]. A
threefold increase in risk for coronary heart disease and
stroke and a marked increase in cardiovascular mortality in
subjects with the metabolic syndrome were also reported
[7]. The main causes of the metabolic syndrome are
overweight/obesity, genetic factors and lifestyle factors
such as physical activity, nutrition, smoking behaviour and
alcohol consumption [9–12]. However, one lifestyle aspect
which has not been studied often in relation to the meta-
bolic syndrome is coffee consumption, even though coffee
is one of the most consumed beverages in the world [13].
The effects of coffee consumption on human health and
in particular the components of the metabolic syndrome,
are found to be inconsistent [3, 14–18]. Most of these
studies however, focused on short term effects of coffee
consumption. Therefore, in the present study the associa-
tions between long term coffee consumption and the
components of the metabolic syndrome were investigated.
All analyses were performed with the use of data from
the Amsterdam Growth and Health Longitudinal Study
(AGAHLS).
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Methods
Study design and subjects
The Amsterdam Growth and Health Longitudinal Study
(AGAHLS) is an observational longitudinal study that
began in 1976 with a group of 450 boys and girls. Its initial
goals were to describe the natural development of growth,
health and lifestyle of adolescents and to investigate lon-
gitudinal relationships between biological and lifestyle
variables. The mean ± SD age of the subjects at the
beginning of the study was 13.1 ± 0.8 years. Since then, a
series of examinations have been performed during a 30-
year follow-up period, collecting data on anthropometric
(body height, body weight, and skin folds), biological
(serum lipoprotein levels, blood pressure and physical fit-
ness), lifestyle (nutritional habits, smoking behaviour, and
daily physical activity), and psychological variables [19].
In the most recent measurement period (2006) at the age
of 42 years, the five components of the metabolic syn-
drome, according to the current guidelines [8], were
measured in 344 subjects. The coffee consumption of the
subjects was measured at the ages of 27, 29, 32, 36 and
42 years. Subjects who missed data of two or more mea-
surements on coffee consumption were excluded from the
analyses.
The study was approved by the medical ethical com-
mittee of the VU University Medical Centre and all
subjects gave their written informed consent.
Metabolic syndrome and its components
Blood pressure was measured in a supine position with an
automated device (Dinamap Procare 100), at 5-min inter-
vals, for 60 min. For blood pressure as a continuous
variable, the Mean Arterial Pressure (MAP) was calculated
as (2*diastolic blood pressure ? 1*systolic blood pres-
sure)/3 [20]. High-density lipoprotein (and total)
cholesterol, triglycerides and fasting blood glucose levels
were measured by enzymatic techniques (Roche Diagnos-
tics, Mannheim, Germany). Waist circumference was
measured with a flexible steel tape (Martin circumeter;
Franken & Itallie) at the level midway between the lowest
rib margin and the iliac crest [21].
The identification of the metabolic syndrome and its
components was based on a slightly modified version of the
definition proposed by the National Cholesterol Education
Program (NCEP) Adult Treatment Panel III [8, 9], i.e.,
when three or more of the following five risk factors were
present: (1) a systolic blood pressure of 130 mmHg or
higher and/or a diastolic blood pressure of 85 mmHg or
higher; (2) a high-density lipoprotein cholesterol level of
less than 1.03 mmol/l in men and less than 1.29 mmol/l in
women; (3) a triglyceride level of 1.69 mmol/l or more; (4)
a fasting plasma glucose levels of 6.1 mmol/l or more; and
(5) a waist circumference of more than 94 cm in men and
more than 80 cm in women, ie, more liberal cut off values
then originally proposed ([102 cm in men and [88 cm in
women), since they may be more appropriate in the iden-
tification of individuals at increased risk in young and
apparently healthy populations [9, 21].
Coffee consumption
Coffee consumption was measured with a questionnaire at
the ages of 27, 29, 32, 36 and 42 years. In the question-
naires, it was asked for how many cups of coffee a subject
drinks during weekdays and how many cups of coffee a
subject drinks during weekend days. Furthermore a dis-
tinction was made between caffeinated and decaffeinated
coffee consumption. The average coffee consumption over
the total measurement period was calculated by taking the
mean of the three, four or five coffee intake measurements
and is expressed in cups/day. In the analyses, no distinction
was made between the types of coffee (filtered, boiled,
instant, pads) and between caffeinated and decaffeinated
coffee.
Covariates
The relationship between components of the metabolic
syndrome and coffee consumption can be influenced by
other lifestyle components [11, 22]. Consequently, possible
confounding factors, such as physical activity, energy
intake, alcohol consumption and smoking behaviour were
taken into consideration.
Physical activity was assessed with a validated interview
and is expressed in MET*min/week. For physical activity,
year specific z-scores were calculated and the values were
averaged over the period from the age of 27 till 36 years.
Energy intake was measured with a cross-check dietary
interview in which the subjects were asked to recall their
usual dietary intake during the previous month. Frequency,
amounts and methods of preparation of the foods and
drinks consumed were reported and values are expressed in
kcal/day. Year specific z-scores were calculated for energy
intake and the values were averaged over the period from
the age of 27 till 36 years. The dietary interview also
provided information about alcohol consumption and the
amount of alcohol consumed (in glasses/week) at the age of
42 years was obtained. Smoking was measured with a
tobacco questionnaire and was divided into three groups
(smokers, non-smokers and subjects who have smoked in
the past, but not anymore).
More detailed information of the methods used in the
AGAHLS can be found elsewhere [19].
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Statistical analysis
To examine the associations between coffee consumption
(averaged over the period from the age of 27 to 42 years)
and the five components of the metabolic syndrome at the
age of 42 years, linear regression analyses were used. In
men, the average coffee consumption between the ages of
27 and 42 years was categorized in four groups (B2, [2
and B4,[4 and B6,[6 cups/day). Coffee consumption in
women was categorized in three groups (B2, [2 and B4,
[4 cups/day) instead of four, as the highest category ([6
cups/day) was combined with the second highest category
([4 and B6), given that the group size of the highest cat-
egory on its own was too small. The categorical variable
was represented in the regression analyses by dummy
variables, where the lowest category (B2 cups/day) was
used as the reference category. This (standard) approach
results in regression coefficients indicating the difference
in a particular outcome variable between the groups with a
different amount of coffee consumption.
Of the outcome variables, triglyceride and fasting blood
glucose were not normally distributed and these variables
were logarithmically transformed to correspond with the
assumptions of regression analysis. All analyses were
performed separately for men and women. Besides the
crude analyses, an adjustment for physical activity, energy
intake, alcohol consumption and smoking was performed.
To evaluate main effects, a 5% significance level was
assumed. All statistical analyses were performed with
SPSS 14.0.
Results
Table 1 shows the characteristics of the population, strat-
ified by gender. Average coffee consumption for men was
4.5 cups/day, for women 3.1 cups/day.
Table 2 shows the prevalence of the metabolic syndrome
and its components. The prevalence of the metabolic syn-
drome at the age of 42 years in the entire population was
only 3.5% (around 8% for men and 0% for women).
Table 3 presents the results of the regression analyses,
showing the effect of 15 years of coffee consumption on
the five components of the metabolic syndrome at the age
of 42 for men. The crude analyses show no significant
effect for any of the variables. In the adjusted model
(adjusted for physical activity, energy intake, smoking
behaviour and alcohol consumption) no significant effects
were found either.
Table 4 presents the results of the same analyses as
Table 3, only for women. The crude analyses show some
borderline significant effects for HDL. It seems that a
moderate coffee consumption ([2 and B4 cups/day), as
well as a high coffee consumption ([4 cups/day) decreases
HDL levels. Although, these effects are just above the 5%
significance level (P = 0.06). Adjustment for physical
activity, energy intake, smoking behaviour and alcohol
consumption, strengthened these associations. Further-
more, MAP appears to decrease with a moderate coffee
consumption ([2 and B4 cups/day), although, this effect
was only borderline significant. For all other components,
no significant effects were found.
Table 1 Mean and standard deviation (between brackets) of subject
characteristics at the age of 42 years (measured in 2006)
Men
(N = 123)
Women
(N = 160)
Coffee total, cups/day 4.5 (2.5) 3.1 (1.9)
B2, no (%) 19 (15.4) 48 (30)
[2 and B4, no (%) 32 (26.0) 62 (38.1)
[4 and B6, no (%) 47 (38.2) 42 (26.3)
[6, no (%) 25 (20.3) 9 (5.6)
Systolic blood pressure 122.2 (13.6) 110.9 (12.6)
Diastolic blood pressure 72.8 (7.7) 67.8 (7.9)
Mean arterial pressure (mmHg)a 89.3 (9.0) 82.2 (9.0)
HDL (mmol/l) 1.5 (0.3) 1.9 (0.4)
Triglycerides (mmol/l) 1.4 (1.1) 1.0 (0.4)
Fasting glucose (mmol/l) 5.2 (1.1) 4.9 (0.5)
Waist circumference (cm) 89.3 (8.1) 77.6 (8.6)
Physical activity (Mets/week)b 3604 (2190) 3931 (1937)
Energy intake (Kcal/day)b 2937 (636) 2257 (419)
Alcohol consumption (glass/
week)c
6.3 (1.9–13.8) 1.9 (0.6–6.3)
Smoking behaviour
Never, no (%) 69 (56.1) 98 (61.3)
Past, no (%) 32 (26.0) 43 (26.8)
Current, no (%) 22 (17.9) 19 (11.9)
a Calculated as (2*diastolic blood pressure ? systolic blood pres-
sure)/3
b Averaged over period from 27 to 36 years
c Median (interquartile range)
Table 2 Prevalence of the components metabolic syndrome
Risk factor Men
(N = 123)
Women
(N = 160)
Blood pressure (C130/85 mmHg) 26 (21.2%) 16 (10.0%)
HDL (\1.03 mmol/l, men;
\1.29 mmol/l, women)
7 (5.7%) 8 (5.0%)
Triglycerides (C1.69 mmol/l) 30 (24.4%) 8 (5.0%)
Fasting blood glucose (C6.1 mmol/l) 8 (6.5%) 3 (1.9%)
Waist circumference ([94 cm, men;
[80 cm, women)
33 (26.8%) 48 (30%)
Metabolic syndromea 10 (8.1%) 0
a 3 (or more) of 5 components
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The effect of coffee consumption on HDL appeared to
be significant in women, but not in men. However, it
should be noted that the difference in the relationship of
HDL and coffee consumption between men and women
was not statistically significant, given the overlapping
confidence intervals.
To explore the relationship between coffee consumption
and HDL in women a bit further, we first added body mass
index (BMI) to the model to investigate whether the rela-
tionship between coffee consumption and HDL was
mediated by BMI. This was not the case; the results of the
analyses did not change (data not shown). In a second
explorative analysis, a multiple regression analyses was
performed in which coffee consumption was analysed in
combination with BMI, waist circumference, physical
activity, smoking behaviour and alcohol consumption.
Table 5 shows the results of this multiple regression
analysis. Also in this multiple regression model, coffee
consumption remains (significantly) related to HDL, while
also alcohol consumption (the more glasses/week, the
higher HDL levels) and waist circumference (the higher
waist circumference, the lower HDL levels) were signifi-
cantly associated with HDL.
Discussion
This study examined the association between coffee con-
sumption and the components of the metabolic syndrome
in a relatively healthy Dutch study population. It appeared
that coffee consumption was inversely associated with
HDL level in women. A significant, inverse relation
between coffee consumption and HDL was found. Fur-
thermore, an almost significant inverse association was
found between average coffee consumption and MAP, and
for men, waist circumference seems to be somewhat
associated with a high coffee consumption.
In the present study, an inverse association was found
between HDL level and average/high coffee consumption
in women. A meta-analysis of randomized controlled trials
(RCT) regarding associations between coffee consumption
and cholesterol, showed that consuming 6 cups/day was
Table 3 Effect (95% confidence interval) of coffee consumption on components of the metabolic syndrome for men
Coffee consumption (cups/day)
[2 and B4 [4 and B6 [6 P for
trend
Crude analysis
Mean arterial pressure (mmHG)a -3.7 (-8.9 to 1.5) -3.6 (-8.5 to 1.3) -0.3 (-5.8 to 5.3) 0.95
P = 0.16 P = 0.15 P = 0.93
HDL (mmol/l)a 0.01 (-0.19 to 0.21) 0.04 (-0.15 to 0.22) -0.05 (-0.25 to 0.16) 0.59
P = 0.90 P = 0.68 P = 0.66
Triglyceride (mmol/l)b 1.07 (0.76 to 1.51) 1.03 (0.75 to 1.40) 1.19 (0.84 to 1.70) 0.44
P = 0.68 P = 0.87 P = 0.34
Fasting glucose (mmol/l)b 1.01 (0.92 to 1.09) 1.03 (0.95 to 1.12) 1.03 (0.94 to 1.12) 0.36
P = 0.91 P = 0.46 P = 0.50
Waist circumference (cm)a 0.7 (-4.0 to 5.3) 0.4 (-4.0 to 4.8) 2.5 (-2.4 to 7.4) 0.37
P = 0.78 P = 0.87 P = 0.32
Adjusted analysisc
Mean arterial pressure (mmHG)a -5.2 (-10.6 to 0.2) -4.7 (-9.8 to 0.4) -1.4 (-7.0 to 4.3) 0.90
P = 0.06 P = 0.07 P = 0.06
HDL (mmol/l)a 0.02 (-0.19 to 0.22) 0.05 (-0.14 to 0.24) -0.05 (-0.26 to 0.16) 0.68
P = 0.87 P = 0.62 P = 0.61
Triglyceride (mmol/l)b 1.03 (0.73 to 1.46) 0.93 (0.67 to 1.30) 1.12 (0.78 to 1.61) 0.71
P = 0.85 P = 0.68 P = 0.53
Fasting glucose (mmol/l)b 1.00 (0.92 to 1.09) 1.01 (0.94 to 1.10) 1.02 (0.93 to 1.11) 0.59
P = 0.94 P = 0.72 P = 0.72
Waist circumference (cm)a 0.5 (-4.4 to 5.5) 0.2 (-4.5 to 4.8) 2.3 (-2.8 to 7.4) 0.42
P = 0.84 P = 0.95 P = 0.37
a Effect is difference in average value with reference category B2 cups/day
b Effect is ratio in average value with reference category B2 cups/day
c Adjusted for energy intake, physical activity, smoking and alcohol consumption
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associated with increased LDL cholesterol, but not with
HDL. A distinct difference in outcome in blood cholesterol
levels appeared between boiled coffee and filtered coffee.
Increases in serum lipids (except for HDL) were greater in
studies where people drank boiled coffee [16]. These dif-
ferences in effect on blood cholesterol between filtered and
unfiltered/boiled coffee were found in several other studies
as well [23–25]. However, at least one trial using filtered
coffee, has shown that coffee consumption was associated
with an increase in total serum cholesterol [26]. The cho-
lesterol raising factors in boiled coffee are cafestol and
kahweol. Two fat-soluble matters, which are originally
present in coffee oil. In particular cafestol is found to raise
blood cholesterol [27]. The population in the present study
drank mostly drip-filtered caffeinated coffee, which does
not contain cafestol and kahweol.
Regarding waist circumference, positive associations
were found in both male and female subjects with a high
coffee consumption. However, these associations were not
statistically significant. To our knowledge there are almost
no studies reporting a relationship between coffee con-
sumption and waist circumference. However, many studies
investigate the relationship between coffee consumption
and body mass index as indicator for body fatness. Positive
Table 4 Effect (95% confidence interval) of coffee consumption on components of the metabolic syndrome for women
Coffee consumption (cups/day)
[2 and BB4 [4 P for trend
Crude analysis
Mean arterial pressure (mmHG)a -3.0 (-6.5 to 0.4) 0.1 (-3.5 to 3.7) 0.94
P = 0.08 P = 0.96
HDL (mmol/l)a -0.15 (-0.30 to 0.01) -0.15 (-0.31 to 0.01) 0.06
P = 0.06 P = 0.06
Triglyceride (mmol/l)b 1.01 (0.87 to 1.17) 1.04 (0.89 to 1.22) 0.58
P = 0.90 P = 0.59
Fasting glucose (mmol/l)b 1.03 (0.99 to 1.07) 1.01 (0.97 to 1.05) 0.58
P = 0.16 P = 0.54
Waist circumference (cm)a 1.4 (-1.9 to 4.7) 2.5 (-1.0 to 5.9) 0.16
P = 0.41 P = 0.16
Adjusted analysisc
Mean arterial pressure (mmHG)a -3.1 (-6.7 to 0.5) -0.1 (-3.8 to 3.7) 0.95
P = 0.09 P = 0.97
HDL (mmol/l)a -0.18 (-0.34 to -0.02) -0.20 (-0.36 to -0.03) 0.03
P = 0.03 P = 0.02
Triglyceride (mmol/l)b 0.98 (0.83 to 1.14) 1.05 (0.90 to 1.24) 0.59
P = 0.75 P = 0.53
Fasting glucose (mmol/l)b 1.02 (0.99 to 1.07) 1.01 (0.97 to 1.05) 0.75
P = 0.20 P = 0.61
Waist circumference (cm)a 1.36 (-2.4 to 4.9) 2.6 (-1.1 to 6.3) 0.17
P = 0.44 P = 0.17
a Effect is difference in average value with reference category B2 cups/day
b Effect is ratio in average value with reference category B2 cups/day
c Adjusted for energy intake, physical activity, smoking and alcohol consumption
Table 5 Results of a multiple regression analysis to explore the
effect of coffee consumption and other risk factors on HDL in women
Effect (95% CI) P-value
Coffee consumptiona
[2 and B4 cups/day -0.17 (-0.32 to -.02) 0.03
[4 cups/day -0.15 (-0.31 to 0.00) 0.06
Alcohol consumption
(glasses/week)
0.02 (0.01 to 0.03) 0.01
Physical activity 0.02 (-0.06 to 0.09) 0.70
Waist circumference -0.02 (-0.04 to -0.01) 0.02
Body mass index 0.01 (-0.03 to 0.04) 0.61
Smoking behaviourb
Past 0.01 (-0.14 to 0.15) 0.91
Current -0.08 (-0.27 to 0.12) 0.45
a B2 Cups/day is used as reference category
b Never smokers is used as reference category
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associations between coffee consumption and body mass
index (BMI) were found in several studies [13, 28, 29].
However, also contrary effects were found. In a prospective
study over a period of 12 years, it appeared that an increase
in caffeine intake, mainly due to coffee consumption, led to
a small reduction in long-term weight gain [30].
In the present study, triglycerides were not associated
with coffee consumption in either men or women. Con-
tradictory to this outcome, a meta-analysis of RCT’s
reported a dose-response relation between coffee con-
sumption and triglycerides [16]. On the other hand, a
longitudinal study in Japan showed that triglyceride levels
were significantly and inversely associated with coffee
consumption [18].
In the present study, blood pressure was to some extent
inversely associated with moderate coffee consumption.
Comparable to this outcome, an inverse association
between coffee and blood pressure was found in a study in
a general Norwegian population [14]. However, in previous
studies it has been suggested that coffee raises blood
pressure. A meta-analysis of RCT’s revealed a significant
association between coffee consumption and both systolic
and diastolic blood pressure [15]. In a more recent meta-
analysis it was suggested that caffeine, when ingested
through coffee, either has a very small, or no effect on
blood pressure [31]. This finding is supported by many
single studies as well [32–35].
For fasting blood glucose, no associations with coffee
consumption were found in the present study. There are
numerous studies, which claim positive health effects of
coffee consumption on diabetes mellitus type II or insulin
resistance. Several studies conclude that caffeine intake,
mainly due to coffee consumption, can reduce risk of DM
II and reduce insulin resistance [3, 13, 30, 36, 37]. The
present study does not support these outcomes. However,
also in a study in which a reduced risk of DM II was found
due to high coffee consumption, no association between
high coffee consumption and fasting plasma glucose levels
was found [38]. On the other hand, Keyzers found an
inverse relationship between insulin sensitivity and caf-
feine in healthy humans [39]. This effect however, was a
short-term effect and was as a result of just (intravenous)
caffeine intake instead of coffee intake.
Limitations
Although this study is probably one of the first in which
long term coffee consumption is related to health out-
comes, a few limitations should be mentioned. This study
was supposed to examine the association between long
term coffee consumption and the metabolic syndrome.
However, the prevalence of the metabolic syndrome in our
study population was only 3.5% (around 8% for men and
0% for women) so it was not possible to analyze this
relationship. This prevalence of the metabolic syndrome in
our study population was extremely low, compared to the
prevalence of the metabolic syndrome for adults in the
Netherlands (15–22% for men and 9–15% for women)
[40].
There are several reasons for not finding strong effects
of coffee consumption on the components of the metabolic
syndrome. First, as mentioned before, the study population
was relatively healthy. Besides the low prevalence for the
metabolic syndrome, the population seemed to be healthy
for the separate components as well (see Table 2). Fur-
thermore, it was not possible to take coffee additives as
milk, cream and sugar into consideration. Although these
variables were not included in our analyses, adjustments
were made for energy intake (kcal/day). Besides this, the
average coffee consumption in the population was
4.5 cups/day for men and 3.1 cups/day for women. These
averages are relatively low compared to existing literature,
while it is known that especially the higher coffee con-
sumption ([6 or[7 cups/day) shows the largest effects [3].
Especially in women, the highest coffee category was
extremely small and had to be combined with the second
highest category.
In conclusion, 15 years of coffee consumption was
inversely associated with HDL and with MAP (the latter
only for moderate coffee consumption) for women. For
men, no significant associations were found between long
term coffee consumption and metabolic syndrome risk
factors.
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